WealthTrust Axiom’s Eastman Chemical EMN Stock Holding History

WealthTrust Axiom’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,855	Closed	-$207K	–	257
2022 Q1	$207K	Sell	1,855 -19	-1%	-$2.23K	0.06%	223
2021 Q4	$226K	Buy	+1,874	New	+$208K	0.07%	214
2021 Q3	–	Sell	-1,879	Closed	-$219K	–	264
2021 Q2	$219K	Buy	+1,879	New	+$226K	0.07%	218

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

WealthTrust Axiom's EMN Position: Q2 2022 in Review

WealthTrust Axiom sold out of Eastman Chemical (EMN) in Q2 2022, closing a stake of 1,855 shares — an estimated $207K sold.

WealthTrust Axiom first reported a position in EMN in Q2 2021 and held it in 3 quarters. The position peaked at $226K in Q4 2021. 688 funds tracked by Wall St. Rank hold EMN as of Q2 2022.

WealthTrust Axiom reported no remaining Eastman Chemical position as of Q2 2022 after selling out during the quarter.
WealthTrust Axiom sold 1,855 Eastman Chemical shares in Q2 2022, an estimated $207K.
WealthTrust Axiom first reported a position in Eastman Chemical in Q2 2021 and held it in 3 quarters.
WealthTrust Axiom's Eastman Chemical position peaked at $226K in Q4 2021.
688 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2022.

Based on WealthTrust Axiom's 13F filing for Q2 2022, filed 27 Jul 2022.